Natural Products and Pharmacognosy

Post on 23-Jan-2017

50 Views

Category:

Health & Medicine

7 Downloads

Preview:

Click to see full reader

Transcript

Natural Products&

PharmacognosySeyed Mohammad ZareiSm.zarei63@gmail.com

June 2016

Natural Products & Pharmacognosy

Introduction about herbal medicine and its history

Definition of pharmacognosy and natural products

Pharmacognosy branches Pharmacognosy scope The role of natural products in drug

discovery

Sumerians and Akkadians (3rd millennium BC) Egyptians (Ebers papyrus, 1550 BC) Hippocrates (460-377 BC) “The Father of Medicine” Dioscorides (40-80 AD) “De Materia Medica” (600

medicinal plants) Ibn Altabari (770-850) “ الحكمه ”فردوس

Ibn Sina (980-1037) “ الطب في ”القانون Ibn Albitar (1148-1197) “ واألغذية األدوية لمفردات ”الجامع

Introduction

The 18th century, Pharmacognosy

Johann Adam (1759-1809)

Carl Linnaeus (naming and classifying plants)

At the end of the 18th century, crude drugs were still being used as powders, simple extracts, or tinctures

The era of pure compounds(In 1803, a new era in the history of medicine)

Isolation of morphine from opium Strychnine (1817) Quinine and caffeine (1820) Nicotine (1828) Atropine (1833) Cocaine (1855)

In the 19th century, the chemical structures of many of the isolated compounds were determined.

In the 20th century, the discovery of important drugs from the animal kingdom, particularly hormones and vitamins.

The late 20th century, pharmacognosy and its conventional botanical approach has been broadened up to molecular and metabolomic level.

Approximately 60% of the world’s population relies almost entirely on plants for medication.

Of the 520 new drugs approved between 1983 and 1994, 39% were natural products or derived from natural products.

Between 1983 and 1994, 60–80% of antibacterials and anticancer drugs were derived from natural products.

Of the 20 best-selling non-protein drugs in 1999, nine were either derived from or developed as the result of leads generated by natural products with combined annual sales of >US$16 billion.

Definitions Pharmacognosy: The study of the physical, chemical, biochemical

and biological properties of drugs, drug substances or potential drugs of natural origin as well as the search for new drugs from natural sources.

Pharmacognosy

Botany Ethno

botanyMarine Biology

Microbiology

Herbal Medicin

ePharmacology

Clinical Pharma

cy

Biotechnology

Pharmaceutics

Chemistry

Phytochemistry

Pharmacognos

y

Marine Pharmacognosy

Medical Ethnobotany

Pharmaceutical Biotechnology

Ethnopharmacology

Phytotherapy

Aromatic Plants

Phytochemistry

Zoopharmacognosy

The study of the traditional use of plants for medicinal purposes.

Medical Ethnobotany

the study of the pharmacological qualities of traditional medicinal substances.

Ethnopharmacology

the study of the use of extracts of natural origin as medicines or health-promoting agents.

Phytotherapy

the process by which animals self-medicate, by selecting and using plants, soils, and insects to treat and prevent disease.

Zoopharmacognosy

The study of chemicals derived from marine organisms.

Marine Pharmacognosy

The study of essential oils, their composition and their use in medicine, cosmetic industries and food industries.

Aromatic Plants

the study of chemicals derived from plants (including the identification of new drug candidates derived from plant sources).Phytochemistry

the science that covers all technologies required for the production, manufacturing natural products using plant cell culture.

Pharmaceutical Biotechnology

Scopes of Pharmacognosy

1- CULTIVATION AND COLLECTION OF MEDICINAL PLANTS

Clove

Cinchona

Cinnamon

Opium

Scopes of Pharmacognosy

2- PREPARATION OF HERBAL FORMULATIONS Echinacea (Echinacea purpurea and related

species) St. John's wort (Hypericum perforatum) Ginkgo (Ginkgo biloba) Garlic (Allium sativum) Saw palmetto (Serenoa repens) Ginseng (Panax ginseng or Asian ginseng)

and Panax quinquefolius or American ginseng)

Goldenseal (Hydrastis canadensis) Valerian (Valeriana officinalis) Chamomile (Matricaria recutita) Feverfew (Tanacetum parthenium) Ginger (Zingiber officinale) Evening primrose (Oenothera biennis) Milk thistle (Silybum marianum)

Scopes of Pharmacognosy

3- ISOLATION OR ANALYSIS OF PHYTOCHEMICAL

Scopes of Pharmacognosy

3- ISOLATION OR ANALYSIS OF PHYTOCHEMICAL Nutraceuticals, or “functional foods”

Scopes of Pharmacognosy4- DRUGS OF DIRECT THERAPEUTIC USES Antibiotics Steroids Ergot alkaloids Anticancers Yohimbine, Thymol, Theophylline, Theobromine, Caffeine,

Morphin, Siymarin, Scopolamine, Reserpine, Ephedrine, Quinidine, Quinine, Pilocarpine, Papaverine, …

Scopes of Pharmacognosy

3- DRUGS OBTAINED BY PARTIAL SYNTHESIS OF NATURAL PRODUCTS:

Cortisone

Progesterone

Diosgenin

Scopes of Pharmacognosy

4- STRUCTURE ACTIVITY RELATIONSHIP STUDIES

Scopes of Pharmacognosy

5- NATURAL PRODUCTS AS MODELS FOR SYNTHESIS OF NEW DRUGS

Morphine Methadone AlfentanilOxymorphone

New Chemical Entities and Medical Indications by Source of Compound 01/1981-06/2006

All new chemical entities by source01/1981-06/2006

N=1184

All available anticancer drugs by source1940s-06/2006

N=175

All antiinfective (antibacterial, antifungul, antiparasitic, antiviral) drugs (N=230)

01/1981-06/2006

There are estimated to be ~250,000 species of plant

in the world and probably ~10% of these have been tested for some type of biological activity.

Only approximately 6000 bacterial species have been named and estimates of 1.5 million species of fungi and 1.5 million species of algae and prokaryote might have to be revised upwards.

it appears that less than 1% of microbial diversity has been cultured and studied experimentally.

There are probably 40,000 species of microalgae, but they have not been extensively studied in terms of their secondary metabolites.

Conclusion Natural products very important to

medicine.

Exist in range of structures that one wouldn’t think of synthesizing.

Can act as templates for new drug development.

Untapped reservoir of new compounds.

Thanks for your attention

Newman, David J., and Gordon M. Cragg. "Natural Products as Sources of New Drugs over the Last 25 Years⊥." Journal of natural products 70, no. 3 (2007): 461-477.

Newman, David J., and Gordon M. Cragg. "Natural product scaffolds as leads to drugs." Future medicinal chemistry 1, no. 8 (2009): 1415-1427.

Kinghorn, A. Douglas. "Pharmacognosy in the 21st century." Journal of Pharmacy and Pharmacology 53, no. 2 (2001): 135-148.

Harvey, Alan. "Strategies for discovering drugs from previously unexplored natural products." Drug discovery today 5, no. 7 (2000): 294-300.

top related